Extracellular Superoxide Dismutase Protects against Proteinuric Kidney Disease

J Am Soc Nephrol. 2015 Oct;26(10):2447-59. doi: 10.1681/ASN.2014060613. Epub 2015 Feb 2.

Abstract

Extracellular superoxide dismutase (EC-SOD), also known as SOD3, is an antioxidant expressed at high levels in normal adult kidneys. Because oxidative stress contributes to a variety of kidney injuries, we hypothesized that EC-SOD may be protective in CKD progression. To study this hypothesis, we used a murine model of ADR nephropathy characterized by albuminuria and renal dysfunction. We found that levels of EC-SOD diminished throughout the course of disease progression and were associated with increased levels of NADPH oxidase and oxidative stress markers. EC-SOD null mice were sensitized to ADR injury, as evidenced by increases in albuminuria, serum creatinine, histologic damage, and oxidative stress. The absence of EC-SOD led to increased levels of NADPH oxidase and an increase in β-catenin signaling, which has been shown to be pathologic in a variety of kidney injuries. Exposure of EC-SOD null mice to either chronic angiotensin II infusion or to daily albumin injections also caused increased proteinuria. In contrast, EC-SOD null mice subjected to nonproteinuric CKD induced by unilateral ureteral obstruction exhibited no differences compared with wild-type mice. Finally, we also found a decrease in EC-SOD in human CKD biopsy samples, similar to our findings in mice. Therefore, we conclude that EC-SOD is protective in CKDs characterized by proteinuria.

Keywords: kidney disease; oxidative stress; podocyte; proteinuria.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Doxorubicin / administration & dosage
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Proteinuria / chemically induced
  • Proteinuria / prevention & control*
  • Renal Insufficiency, Chronic / chemically induced
  • Renal Insufficiency, Chronic / prevention & control*
  • Superoxide Dismutase / physiology*
  • Superoxide Dismutase / therapeutic use*

Substances

  • Doxorubicin
  • Sod3 protein, mouse
  • Superoxide Dismutase